Answers are grounded in this paper and cite their sources.
Up to 50% of patients with colorectal cancer will develop metastatic disease in the liver. While surgical extirpation remains the best option for long‐term survival, several complementary modalities such as laparoscopy, radiofrequency ablation, and microwave coagulation have gained wide acceptance as primary and adjunct therapies for both resectable and unresectable disease. This review will focus on the application and outcome of these techniques in patients with colorectal liver metastases. J. Surg. Oncol. 2010;102:968–974.
No takes yet. Share an insight, caveat, or question.
Rocha et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: